Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
Date:2/14/2008

:15 p.m. EST start time. There will be a playback available until March 15, 2008. To listen to the playback, please call 800- 406-7325 from within the United States, or US +1-303-590-3030 internationally. Please use pass code 3843464 for the replay. The call will also be Web cast at the following link: http://viavid.net/dce.aspx?sid=00004BD5

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 51 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 523 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with two manufacturing facilities and a total of 869 employees. Tianyin achieved revenue of $20.4 million and net income of $3.95 million in FY2007 ending June 30, 2007.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

--
'/>"/>

SOURCE Tianyin Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... TriPollar Technology- the most advanced 3rd generation Radio Frequency solution for ... clinically proven the world over to be safe and effective on ... patients enjoy visible results from the very 1st treatment. Long ... , ... Tel Aviv, Israel (PRWEB) December 1, ...
(Date:12/4/2009)... Dec. 4 Vivakor, Inc. (OTC Bulletin Board: VIVK) ... 1, 2009 will receive the dividend of shares of ... by Vivakor,s Board of Directors. HealthAmerica is a ... of the outstanding common shares on the record date. ...
(Date:12/3/2009)... Dec. 3 Nikon Corporation, an innovator of ... signed a licensing agreement with Harvard University granting ... Reconstruction Microscopy (STORM) technology. Under the terms of ... systems and market them with the N-STORM name. ...
(Date:12/3/2009)... (NYSE: IMA ), a global leader in enabling ... the merger of rapid diagnostics and health management, has declared ... Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will be ... per share equal to the quotient of (a) $3.00 divided ...
Breaking Biology Technology:Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3
... ... - Operating margin of 9.9% for the quarter,- Record backlog of over $2 ... ... today announced its financial results for the,fourth quarter and Fiscal Year ended June 30, 2008., For ...
... Partners announced today that,it has updated coverage and has ... INO ). "The proposed merger of Inovio and ... and deliver,therapeutic agents and positions Inovio/VGX, based on further ... other gene therapy,companies," said Ross Silver, Director of Research ...
... N.J., Aug. 6 Millennium,Biotechnologies, Inc., a wholly ... Board: MBTG) today named Mark C.,Mirken its new ... of,Directors., Mirken has been President and Chief ... in September of 2007. Mirken will replace Jerry,Swon ...
Other Biology Technology:PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 3PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 4PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 5PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 6PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 7PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 8PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 9PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 10PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 11PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 12PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 13PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 14Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target 2Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. 2Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. 3
(Date:12/4/2009)... This release is available in German . ... Biology of Ageing could help to understand the positive effect ... organisms (fruit flies and mice) have shown that dietary restriction ... diminished fertility. So the female fruit fly reproduces less frequently ...
(Date:12/3/2009)... new information and adapt to changes in our daily environment, ... in the minute junctions where nerve cells communicate, according to ... study is published online this week in the journal ... PhD, associate professor of physiology and neuroscience at NYU School ...
(Date:12/3/2009)... believe that staph infections are caused by many bacterial cells ... is called quorum sensing because many bacteria must be present ... group has determined that the very first stage of staph ... form, occurs in a single cell and that this individual ...
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 1NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 3Child Neurology Foundation Announces 2430 000 Grant for Research Into Cause and Treatment of Infantile Spasms 60236 1Child Neurology Foundation Announces 2430 000 Grant for Research Into Cause and Treatment of Infantile Spasms 60236 2Child Neurology Foundation Announces 2430 000 Grant for Research Into Cause and Treatment of Infantile Spasms 60236 3Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 1Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 2
... in Quartier Concordia along Ste. Catherine street or De ... see a demonstration of innovative Canadian technology conceived at ... of one facade of an institutional building - the ... world-first demonstration of this type of combined solar heat ...
... Congress of the International Osteoporosis Foundation and the European ... Osteoarthritis, to be held in Florence, Italy from May ... opportunity for clinicians and researchers from around the world ... field of osteoporosis and osteoarthritis. The,congress will offer an ...
... being forced to say no to a child crying for ... imagine it; that was normal life at her family,s dinner ... phenylketonuria (PKU), a genetic disease that means her body can,t ... described by scientists as an autosomal recessive genetic disease that ...
Other Biology News:A world-first in solar technology unveiled at Concordia University 2New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 2New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 3
... reagent kit for determining the absolute count ... samples, mobilized peripheral blood samples, and leukapheresis ... total nucleated cell count and a total ... designed for use in the BD Procount ...
... 3′-(α-Amino- p- methoxyhydrocinnamamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl ... MOISTURE. Protein synthesis inhibitor. Inhibits translation ... polypeptide chains. Induces DNA fragmentation in ... cells. Purity: ≥98% by TLC. ...
... Stabilizer is a bovine protein-free alternative ... is an aqueous solution that contains ... buffer (3-(N-Morpholino) propanesulfonic acid), pH 6.0 ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane ...
... DNA quantitation kit is used to quantitate double-stranded ... of RNA or protein. With this kit, DNA ... be detected with a VersaFluor or other fluorometer. ... 10 ng per ml to 5 micrograms per ...
Biology Products: